Quality of Life Differences for Primary Immunodeficiency Patients on Home SCIG versus IVIG

BACKGROUND: Patients with primary immunodeficiency disease (PIDD) and antibody deficiency require lifelong immunoglobulin replacement therapy. While both subcutaneous immunoglobulin (SCIG) and intravenous immunoglobulin (IVIG) replacement therapy are effective in preventing infection, patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Anterasian, Christine, Duong, Richard, Gruenemeier, Peg, Ernst, Carol, Kitsen, Jessica, Geng, Bob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863943/
https://www.ncbi.nlm.nih.gov/pubmed/31673923
http://dx.doi.org/10.1007/s10875-019-00705-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863943/
https://www.ncbi.nlm.nih.gov/pubmed/31673923
http://dx.doi.org/10.1007/s10875-019-00705-5

Ejemplares similares